Edition:
United States

Profile: Neurosearch A/S (NEUR.CO)

NEUR.CO on Copenhagen Stock Exchange

4.33DKK
16 May 2019
Change (% chg)

-- (--)
Prev Close
kr.4.33
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
26,862
52-wk High
kr.4.95
52-wk Low
kr.3.10

Neurosearch A/S (NEUR) is Denmark-based biopharmaceutical company. It specializes in the research, development and sale of drug candidates. The Company’s portfolio comprises three products: Tesofensine, a drug used in obesity, which works as a monoamine reuptake inhibitor (MRI); Seridopidine, which is applied in central nervous system (CNS) diseases and acts as a dopaminergic stabilizer; and Ordopidine, a medicine, which also is involved in the CNS disease treatment as a dopaminergic stabilizer. Furthermore, the Company operates through three wholly owned subsidiaries, NeuroSearch Sweden AB, Poseidon Pharmaceutical A/S and NsExplorer A/S, as well as through affiliates, such as Atonomics A/S and NsGene A/S.

Company Address

Neurosearch A/S

Hammerholmen 47
HVIDOVRE     2650
P: +4544.608000
F: +4544.608080

Company Web Links